Bristol Myers drug fails main goal in cancer-linked anemia trial – Reuters

Written by

admin

in

  1. Bristol Myers drug fails main goal in cancer-linked anemia trial  Reuters
  2. Bristol Myers Squibb’s Reblozyl fails Phase 3 in anemia; Sanofi, Blueprint deal closes  Endpoints News
  3. Retail Chatter On BMY Doubles In 24 Hours With Drug Failing To Meet Primary Goal: Here’s What Investors Are Thinking  Stocktwits
  4. Buy Rating for Disc Medicine: DISC-0974’s Potential in Myelofibrosis-Related Anemia  TipRanks
  5. Bristol Myers Squibb Announces Topline Results from Phase 3 INDEPENDENCE Trial for Reblozyl® (luspatercept-aamt) in Adult Patients with Myelofibrosis-Associated Anemia  BioSpace

Continue Reading

More posts